BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12577084)

  • 1. Cerebrovascular disease in type 2 diabetes mellitus.
    Dalal PM; Parab PV
    Neurol India; 2002 Dec; 50(4):380-5. PubMed ID: 12577084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A global platelet test of thrombosis and thrombolysis detects a prothrombotic state in some patients with non-insulin dependent diabetes and in some patients with stroke.
    Nakajima S; Noguchi T; Taka T; Ueda T; Kaizu K; Fukamizu M; Fujita S; Tabuchi M; Yamamoto J
    Platelets; 2000 Dec; 11(8):459-66. PubMed ID: 11177445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome.
    Tuttolomondo A; Pinto A; Salemi G; Di Raimondo D; Di Sciacca R; Fernandez P; Ragonese P; Savettieri G; Licata G
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):152-7. PubMed ID: 17702553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke in patients with diabetes mellitus.
    Mankovsky BN; Ziegler D
    Diabetes Metab Res Rev; 2004; 20(4):268-87. PubMed ID: 15250030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral vascular pathology in diabetes].
    Arquizan C
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():29-32. PubMed ID: 15666479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
    Stefanović V; Antić S
    Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sugar and stroke: cerebrovascular disease and blood glucose control.
    Quinn TJ; Dawson J; Walters MR
    Cardiovasc Ther; 2011 Dec; 29(6):e31-42. PubMed ID: 20491782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis.
    Rahman S; Rahman T; Ismail AA; Rashid AR
    Diabetes Obes Metab; 2007 Nov; 9(6):767-80. PubMed ID: 17924861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50].
    Guan H; Liu ZM; Li GW; Guo XH; Xu ZR; Zou DJ; Xing HL; Liu W; Sheng ZY; Tian HM; Zhu DL; Yu DM; Zhuang WT; Chen LL; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):23-7. PubMed ID: 17403307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of carotid stenosis in type 2 diabetic patients asymptomatic for cerebrovascular disease.
    De Angelis M; Scrucca L; Leandri M; Mincigrucci S; Bistoni S; Bovi M; Calabrese G; Pippi R; Parretti D; Grilli P; Colorio P; Fattorini M; Flamini O; Pacetti E; Travaglini A; Santeusanio F
    Diabetes Nutr Metab; 2003 Feb; 16(1):48-55. PubMed ID: 12848305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case control study between diabetic and non-diabetic subjects with ischemic stroke.
    Pinto A; Tuttolomondo A; Di Raimondo D; Di Sciacca R; Fernandez P; Di Gati M; Arnao V; Licata G
    Int Angiol; 2007 Mar; 26(1):26-32. PubMed ID: 17353885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetes mellitus and stroke].
    Licata G; Tuttolomondo A; Sinagra D; Pinto A
    Ital Heart J Suppl; 2002 May; 3(5):471-7. PubMed ID: 12064185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischaemic strokes: management in first six hours.
    Dalal PM
    Neurol India; 2001 Jun; 49(2):104-15. PubMed ID: 11447428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stroke prevention in diabetes and obesity.
    Kurukulasuriya LR; Govindarajan G; Sowers J
    Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):487-502. PubMed ID: 16918267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
    Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM;
    Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
    Kirshner HS
    J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of diabetic patients with respect to prevention of macrovascular disease.
    Tkác T
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S338-42. PubMed ID: 14704865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and cerebrovascular disease: which are the actual data?
    Hatzitolios AI; Didangelos TP; Zantidis AT; Tziomalos K; Giannakoulas GA; Karamitsos DT
    J Diabetes Complications; 2009; 23(4):283-96. PubMed ID: 18358748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetes and ischemic heart disease: specific treatment].
    Raddino R; Bonadei I; Teli M; Robba D; Caretta G; Madureri A; Zanini G; Pedrinazzi C; Vizzardi E; Cas LD
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):52S-55S. PubMed ID: 19195307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.